HIV Citations List: March 2023
Literature Citations
1. Antiretroviral APOBEC3 Cytidine deaminases Alter HIV-1 Provirus Integration Site Profiles. Ajoge, H.O., T.M. Renner, K. Bélanger, M. Greig, S. Dankar, H.P. Kohio, M.D. Coleman, E. Ndashimye, E.J. Arts, M.A. Langlois, and S.D. Barr. Nature Communications, 2023. 14(1): p. 1-16. PMID[36627271]. PMCID[PMC9832166].
[PubMed]. HIV_03_2023.
2. The Antiviral Compound PSP Inhibits HIV-1 Entry via PKR-dependent Activation in Monocytic Cells. Alvarez-Rivera, E., M. Rodríguez-Valentín, and N.M. Boukli. Viruses, 2023. 15(3): p. 804-827. PMID[36992512]. PMCID[PMC10051440].
[PubMed]. HIV_03_2023.
3. Synthesis of C3,C6-Diaryl 7-azaindoles via One-pot Suzuki-Miyaura Cross-coupling Reaction and Evaluation of Their HIV-1 Integrase Inhibitory Activity. Cardoza, S., P. Yadav, A. Ajmani, P. Das, and V. Tandon. ACS Omega, 2023. 8(9): p. 8415-8426. PMID[36910947]. PMCID[PMC9996623].
[PubMed]. HIV_03_2023.
4. Design, Synthesis, and Biological Testing of Biphenylmethyloxazole Inhibitors Targeting HIV-1 Reverse Transcriptase. Carter, Z.J., K. Hollander, K.A. Spasov, K.S. Anderson, and W.L. Jorgensen. Bioorganic & Medicinal Chemistry Letters, 2023. 84: 129216. PMID[36871704].
[PubMed]. HIV_03_2023.
5. Indoline CD4-mimetic Compounds Mediate Potent and Broad HIV-1 Inhibition and Sensitization to Antibody-dependent Cellular Cytotoxicity. Fritschi, C.J., S. Anang, Z. Gong, M. Mohammadi, J. Richard, C. Bourassa, K.T. Severino, H. Richter, D. Yang, H.C. Chen, T.J. Chiu, M.S. Seaman, N. Madani, C. Abrams, A. Finzi, W.A. Hendrickson, J.G. Sodroski, and A.B. Smith, 3rd. Proceedings of the National Academy of Sciences of the United States of America, 2023. 120(13): e2222073120. PMID[36961924].
[PubMed]. HIV_03_2023.
6. Evaluation of Darunavir-derived HIV-1 Protease Inhibitors Incorporating P2' Amide-derivatives: Synthesis, Biological Evaluation and Structural Studies. Ghosh, A.K., D. Shahabi, M. Kipfmiller, A.K. Ghosh, M. Johnson, Y.F. Wang, J. Agniswamy, M. Amano, I.T. Weber, and H. Mitsuya. Bioorganic & Medicinal Chemistry Letters, 2023. 83: 129168. PMID[36738797]. PMCID[PMC10061991].
[PubMed]. HIV_03_2023.
7. Antiviral and ROS Scavenging Potential of Carica papaya Linn and Psidium guajava Leaves Extract against HIV-1 Infection. Jadaun, P., P. Shah, R. Harshithkumar, M.S. Said, S.P. Bhoite, S. Bokuri, S. Ravindran, N. Mishra, and A. Mukherjee. BMC Complementary Medicine and Therapies, 2023. 23(1): p. 82-95. PMID[36934258]. PMCID[PMC10024014].
[PubMed]. HIV_03_2023.
8. Development of Fluorine-substituted NH2-biphenyl-diarylpyrimidines as Highly Potent Non-Nucleoside Reverse Transcriptase Inhibitors: Boosting the Safety and Metabolic Stability. Jin, X., S. Wang, L. Zhao, W. Huang, Y. Zhang, C. Pannecouque, E. De Clercq, G. Meng, H. Piao, and F. Chen. Acta Pharmaceutica Sinica B, 2023. 13(3): p. 1192-1203. PMID[36970200]. PMCID[PMC10031149].
[PubMed]. HIV_03_2023.
9. Anti-human Immunodeficiency Virus-1 Activity of MoMo30 Protein Isolated from the Traditional African Medicinal Plant Momordica balsamina. Khan, M., A. Diop, E. Gbodossou, P. Xiao, M. Coleman, K. De Barros, H. Duong, V.C. Bond, V. Floyd, K. Kondwani, V.M. Rice, S. Harris-Hooker, F. Villinger, and M.D. Powell. Virology Journal, 2023. 20(1): p. 50-64. PMID[36949470]. PMCID[PMC10035133].
[PubMed]. HIV_03_2023.
10. Adipocyte Differentiation of 3T3-L1 Cells Under Tenofovir Alafenamide, Tenofovir Disoproxil Fumarate, and Integrase Strand Transfer Inhibitors Selective Challenge: An In-vitro Model. Perna, A., M.A. Carleo, S. Mascolo, A. Guida, M. Contieri, C. Sellitto, E. Hay, P. De Blasiis, A. Lucariello, G. Guerra, A. Baldi, A. De Luca, P. Maggi, and V. Esposito. AIDS, 2023. 37(4): p. 561-570. PMID[36504092]. PMCID[PMC9994803].
[PubMed]. HIV_03_2023.
11. Pyranonaphthoquinones and Naphthoquinones from the Stem Bark of Ventilago harmandiana and Their anti-HIV-1 Activity. Saisin, S., K. Panthong, S. Hongthong, C. Kuhakarn, S. Thanasansurapong, A. Chairoungdua, K. Suksen, R. Akkarawongsapat, C. Napaswad, S. Prabpai, N. Nuntasaen, and V. Reutrakul. Journal of Natural Products, 2023. 86(3): p. 498-507. PMID[36787536]. PMCID[PMC10043937].
[PubMed]. HIV_03_2023.
12. In Vitro Evaluation of bis-3-Chloropiperidines as RNA Modulators Targeting TAR and TAR-Protein Interaction. Sosic, A., G. Olivato, C. Carraro, R. Göttlich, D. Fabris, and B. Gatto. International Journal of Molecular Sciences, 2022. 23(2): p. 582-593. PMID[35054766]. PMCID[PMC8776071].
[PubMed]. HIV_03_2023.
13. Using a Bioactive Eremophila-derived Serrulatane Scaffold to Generate a Unique Carbamate Library for Anti-infective Evaluations. Zhang, C., K.Y. Lum, A.C. Taki, R.B. Gasser, J.J. Byrne, L.J. Montaner, I. Tietjen, V.M. Avery, and R.A. Davis. Journal of Natural Products, 2023. 86(3): p. 557-565. PMID[36799121].
[PubMed]. HIV_03_2023.
14. Discovery of bis-Imidazoline Derivatives as New CXCR4 Ligands. Zhou, Z., I. Staropoli, A. Brelot, P. Suzanne, A. Lesnard, F. Fontaine, S. Perato, S. Rault, O. Helynck, F. Arenzana-Seisdedos, J. Sopkova-de Oliveira Santos, B. Lagane, H. Munier-Lehmann, and P. Colin. Molecules, 2023. 28(3): p. 1156-1174. PMID[36770826]. PMCID[PMC9920567].
[PubMed]. HIV_03_2023.
Patent Citations
This month, no relevant HIV patents were identified.